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Highlights 
- Increased NIHR –adopted clinical trial activity is associated with reduced mortality.  
- Increased NIHR-adopted clinical trial activity is associated with better CQC outcomes. 
- Particularly the number of clinical trial patients correlates with improved hospital 
performance. 
- The link between clinical trials activity and quality is not Trust-size dependent. 
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Abstract  
Objectives: Evidence supporting the notion that clinical research activity in itself is of benefit to 
organisations as a whole is inconclusive. In the recent past, a positive association between research 
activity and reduced mortality has been shown. This study aimed to ascertain if clinical research 
activity is associated with established organisational outcome measures. 
Study design: Retrospective cross-sectional study. 
Methods: For 129 English NHS hospital Trusts, National Institute for Health Research (NIHR) study 
activity data, Summary Hospital-level Mortality Indicator (SHMI) scores and Care Quality 
Commission (CQC) ratings were collected. Research activity was controlled for Trust size by dividing 
it by clinical staffing levels. Multiple linear regression and Spearman correlation analyses were 
performed. 
Results: Although there is a significant association between the number of studies and participants 
with both SHMI score and CQC rating, one particular variable is correlated more significantly than 
others: the number of participants recruited into interventional studies. It shows a significant 
correlation with better CQC ratings (standardised coefficient beta 0.26, p-value 0.003) and lower 
SHMI scores (stand coeff beta -0.50, p-value 0.001). 
Conclusions: The mortality-related results corroborate with other published data showing a 
correlation between increased research and reduced deaths. Furthermore, there is also a 
statistically significant association between clinical trials activity and improved CQC ratings. 
However, these tie-ins are predominantly driven by the number of participants in interventional 
research rather than observational research activity. 
 
Key Words: National Institute for Health Research (NIHR), Care Quality Commission (CQC), Summary Hospital-
level Mortality Indicator (SHMI), clinical trials, interventional research, National Health Service (NHS) 
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Introduction 
Since its inception in 2006, the UK National Institute for Health Research (NIHR) has transformed the 
clinical research landscape in the UK. Its mission, ‘To provide a health research system in which the 
NHS supports outstanding individuals working in world-class facilities, conducting leading-edge 
research focused on the needs of patients and the public’, is backed by expenditure of more than 1 
billion GBP.1 Money is primarily spent on provision of research grants for projects and also delivery 
staff based in National Health Service (NHS) Trusts to deliver both NIHR-funded and other peer-
reviewed and funded studies. The sizeable amount of money spent on clinical research in the UK by 
the NIHR has not increased the number of studies appraising the effect it may have on the overall 
functioning of the NHS Trusts hosting and conducting its research.2 Reduced mortality rates have 
been linked with increased NIHR-adopted clinical research activity and academic output within NHS 
Trusts respectively.3,4 Furthermore, one study demonstrated that colorectal patients participating in 
NIHR-adopted oncology trials survived longer and were at lower risk of death after surgery.5  Other 
cohort studies investigating the potential  associations between research activity and other patient 
& organisational outcome measures, including hospital length-of-stay and adherence to clinical 
guidelines, have produced more mixed results.6 A more recent review of literature, led to Boaz et al, 
concluded that there is a positive association between engagement in research by healthcare 
organisations and improvements in healthcare performance; a caveat being that all 33 source articles 
in that review involved different specialties rather than whole organisations.7 
In this study we test the hypothesis that NIHR-adopted clinical research activity in NHS Trusts is 
associated with improved mortality rates, represented by the Summary Hospital-level Mortality 
Indicator (SHMI), and better organisational performance, represented by Care Quality Commission 
(CQC) ratings. 
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Methods 
Ethics statement and data sources 
This concerns a retrospective cross-sectional study of English NHS hospital Trusts. All data used in 
this study is readily available to the public via NHS and NIHR electronic depositories. The NIHR 
research activity data has been published in the past by the Guardian newspaper’s website. No 
personal identifiable information has been used as part of this study. Therefore, from an ethics 
point of view this is classed a service evaluation and no formal ethics-clearance is required.  
NIHR research activity was obtained from NIHR Open Data Platform website; this information is 
also published annually on the NIHR website.8 Totals for the years 2012-13, 2013-14, 2014-15, 
2015-16 and 2016-17 were calculated for the total number of studies and recruited participants, 
and separately for observational & large scale studies (‘observational’) and interventional & 
commercial studies (‘interventional’). Of the variables included, research activity can be subject to 
significant year-on-year variability due to e.g. a single high-recruiting study being conducted in a 
single year. Clinical staffing numbers, determined in August 2016, per NHS Trust were obtained 
from NHS Digital.9  
The Care Quality Commission is an independent regulator of health and social care in England. 
Organisations intending to provide such services have to register with the CQC, and this therefore 
includes NHS hospitals. Organisations are monitored and inspected based on five key questions 
that are asked by the CQC, namely whether care is: safe, effective, caring; responsive. Failure to do 
so may result is registration being revoked.10 CQC ratings were obtained from the CQC website; the 
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latest rating for each Trust was used for analysis.10 The SHMI is the ratio between the actual number of 
patients who die following hospitalisation at a given NHS Trust hospital and the number that would be 
expected to die on the basis of average England figures, whilst taking into account the characteristics of the 
patients treated there. It covers all deaths reported of patients who were admitted to non-specialist acute 
trusts in England and either die while in hospital or within 30 days of discharge. The statistical models are 
derived using a three-year dataset from trusts throughout England. Data from the final year of this period 
are used to calculate the SHMI and accompanying contextual indicators for each individual trust.11 The 
average SHMI value for each NHS Trust for the calendar years 2014, 2015 and 2016 was calculated 
after obtaining data for each calendar year from the NHS Digital web pages.11 To minimise basing 
analysis on incidental higher mortality rates for NHS Trusts we applied an average of three years, 
an approach taken by others in the past.12  
 
Data processing and analyses 
Data was collected in Excel and transferred to SPSS v20 for analysis. NIHR research activity can 
fluctuate year-on-year and hence a total of five years was combined to counteract any variance. 
Trusts can be split by size, since they are officially classed as small-, medium-, large-sized and acute 
teaching status, which introduces stratification. To maintain one sample, the total research activity 
(studies and also participants recruited) was divided by the clinical staff number for each Trust to 
correct for Trust size. This produces a ‘studies quotient’ and a ‘participants quotient’ (ie number of 
active NIHR studies or number of recruited participants divided by the Trust clinical staff number). 
Spearman correlation analyses and multiple linear regression analyses were conducted. Since CQC 
rating is an ordinal dependent variable, ordinal regression analysis was performed first for this 
dependent variable to validate if the results of the ordinal and multiple linear regression analysis 
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gave comparable outcomes; for the purpose of comparability with the SHMI dependent variable, 
results from multiple linear regression analysis are presented. Overall number of studies and 
participants were not included in multiple linear regression analysis models to minimise risk of 
multicollinearity. A p-value of < 0.05 was considered statistically significant. NHS Trusts often 
operate more than one hospital; however, the terms ‘Trust’ and ‘hospital’ are used 
interchangeably and are meant to indicate the same throughout the text.    
Results.  
SHMI and CQC data was available for 129 English NHS Hospital Trust that have existed for the collated 
five years of NIHR research activity. Specialty NHS Trusts, such as children’s, ophthalmology and 
orthopaedic hospitals, were not included since they do not offer the gamma of services provided in 
an average acute hospital. First, individual variables were correlated with the SHMI score and CQC 
rating respectively (see Table 1). Apart from the number of participants recruited into observational 
studies versus CQC rating and the number of interventional studies versus SHMI, all other variables 
correlated significantly with CQC rating and SHMI score. Where significantly associated, an increase 
in research activity is correlated with a better CQC rating and lower SHMI score respectively. Multiple 
linear modelling of the four independent variables (interventional studies, interventional 
participants, observational studies, observational participants) established that the variable most 
associated with improved CQC rating and SHMI mortality score is the number of patients recruited 
into interventional studies (the interventional participants quotient, see Tables 2 and 3). Figures 1 
and 2 visualise the significant correlation between the number of patients enrolled in interventional 
research studies, which includes clinical trials involving medicinal products but also medical device 
studies and non-medicinal intervention studies such as counselling, and CQC & SHMI. When the 
figures for recruitment of participants into interventional studies are appraised per Trust, it shows 
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that the majority of top performing organisations are acute teaching hospitals. The median 
interventional participants quotient per Trust size are as follows: acute teaching, 1.72; large, 0.70; 
medium, 0.60; small 0.45 (for more in-depth overview of performance per Trust size see Supplement 
1). Despite correction for Trust size, research activity is still approximately double for acute teaching 
Trusts compared to smaller sized Trusts. Therefore, analyses were repeated with acute teaching 
hospitals taken out of the equation, leaving 100 NHS Trusts to analyse. Spearman regression analysis 
showed that only recruitment of participants into interventional studies is significantly associated 
with CQC rating (rho 0.23, p-value 0.024); the comparison with SHMI was non-significant (rho -0.093, 
p-value 0.36).  Backward multiple linear regression again resulted in interventional participants 
quotient being the variable associated the most with both CQC rating (stand coeff beta 0.19, p-value 
0.062) and SHMI score (stand coeff beta -0.31, p-value 0.014; see Supplement 2).  
Discussion 
Ozdemir et al.4 showed a significant association between NIHR clinical research activity and reduced 
mortality, with a focus on research funding per Trust to represent research activity. Our results are 
in agreement with their findings despite some variations in source data and methodology. In their 
paper NIHR activity data from one year, 2010-11, was used and Trust size was corrected using more 
than just Trust staff levels; they calculated mortality rates themselves whereas we used the now 
established SHMI, which was first used in 2010. Our approach of using only staffing levels to control 
for Trust size does not take into account e.g. vacancy factors (which are only published at regional 
level). Nonetheless, both studies have produced comparable outcomes. In our study we have 
addressed two discussion points raised by Ozdemir and colleagues: whether the positive link 
between NIHR-adopted research activity and mortality persists over time and if there is a difference 
between different types of research. The positive association persists over time, and only 
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interventional research shows a persistently significant association with lower mortality rates. The 
SHMI was originally developed to identify outliers in a cohort of hospitals.13 There have long been 
discussions on the merit of a mortality index as an indicator of healthcare quality, and some are of 
the opinion that they cannot be used as an indicator as such.12,14 Despite having its critics, the SHMI 
was deemed the most suitable outcome measure to assess if we could corroborate Ozdemir’s 
findings, because it is available for all English NHS hospital Trusts; an added benefit is that it is 
published per Trust rather than per hospital. It does however highlight that mortality alone may not 
be sufficient when assessing the potential impact that clinical research may have on organisation-
wide performance. 
The positive association between clinical research activity and the healthcare quality indicator CQC 
rating adds weight to the positive correlation found for mortality through SHMI. A previous 
publication failed to identify an association between NIHR clinical research activity and CQC ratings.15 
However, unlike in that paper, the present study did not stratify the cohort by Trust size, apart from 
sub-analysis without teaching hospitals; we instead controlled for Trust size through consideration 
of Trust staff levels. Furthermore, a longer period of research activity was now used – five versus one 
year – to minimise the impact of incidental peaks and troughs in activity. The link between research 
activity levels and CQC ratings suggests that the positive effects clinical research may reach various 
departments and staff in a NHS Trust. CQC ratings are a compound score of a Trust’s performance, 
aimed to assess if services are safe, effective, caring, responsive (to patient needs) and well-led. They 
also collate the views from patients and staff alike on how they feel a Trust is performing. Therefore, 
our data implies that Trusts engaging in clinical research may have low levels of never events and 
avoidable infections, and high levels of positive staff and patient feedback. To take an example, 
higher levels of staff engagement have been shown to be significantly associated with better Trust 
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performance.16 Engagement in delivery of interventional research certainly requires staff 
engagement and team work; possibly more so than an average observational study. Nonetheless, 
caution should be applied in terms of the extent to which clinical research may influence mortality 
rates and CQC ratings, since the effect size of the associations found here are generally small. 
Furthermore, human factors would have to be studied in future studies to explore this further. 
Since the NIHR funds all acute Trusts in England – along with other specialty, community, and mental 
NHS Trusts and GP practices – it is encouraging to observe that the positive association between 
clinical research and CQC and SHMI outcomes goes beyond acute teaching hospitals. This echoes the 
findings by Downing and colleagues that positive effects research participation are not confined to 
large regional tertiary centres.5 Our focus on NIHR-adopted research as a measure of overall research 
activity means that other non-adopted research, including some commercial research conducted by 
NHS Trusts in collaboration with pharmaceutical companies, was not considered. The reason for this 
is two-fold: non-NIHR activity is not published anywhere, and more and more pharmaceutical and 
medical device companies conduct their research through the NIHR route, and therefore the portion 
of non-NIHR research is decreasing.  The issue of limited data availability – particularly clinical 
research activity data - may also hamper efforts to replicate the findings of this present study in 
another country. In the past other correlation studies have been conducted across different 
European countries, including the association between nursing staff levels and hospital mortality 
rates17, and therefore it may not be insurmountable to determine if the association between clinical 
research and improved quality of care is an international phenomenon.  
The findings of this study raise the question: why is interventional research, rather than 
observational research, associated with increased Trust performance?  There may be a number of 
factors driving this distinction. First, patients enrolled in interventional studies may directly benefit 
 
 
10 
 
from being in the study due to a) an improved treatment being offered, and/or b) being treated in 
accordance to the latest applicable guidelines for the condition in question, and/or c) potentially 
being monitored more closely as part of the trial. Conversely, an enormous observational study like 
COSMOS18 - which has recruited 105,000 participants and investigates the health effects of mobile 
phone use - is less likely to result in a change in care for those taking part. Secondly, positive 
outcomes from trials may be incorporated into clinical practice more rapidly when a Trust has 
participated in those trials. This has been demonstrated in various settings, from oncology units to 
operating theatres.19,20 Thirdly, interventional research, which in our analyses included commercial 
activity, may also generate more income than contributions to observational research.21 This in turn 
allows reinvestment in Trust equipment and infrastructure, or investment in staff training, for 
example. It is, however, unlikely that novel treatment themselves contribute solely and directly to 
improved mortality rates and Trust performance. NIHR research activity has grown in the last 
decade, but the total number of recruited patients in 2015-16 for 2,678 interventional studies was 
still only 0.23% (204,745 participants /  89.4 million attended consultations; data sources NIHR ODP 
and NHS Digital respectively) of the total out-patient appointments for the year 2016-17. This 
percentage will be slightly higher when follow-up visits for trial patients are taken into account. 
Unpicking the exact mechanism, if indeed there are defined causative factors underlying our finding 
and those by others, remains difficult partly because standard methodological approaches like a 
prospective randomised trial of engagement in research and a lack of research activity is not 
feasible.22 Retrospective studies and outcome research may be indicated to further investigate this 
phenomenon – termed ‘trial effect’ by Clarke & Loudon - where interventional clinical research 
seems to benefit the patients enrolled in the trials and the organisation delivering the research.6, 23 
Due to the retrospective non-controlled nature of this study, and the risk of confounding, one cannot 
state that the clinical research per se drives favourable mortality rates and CQC ratings.24 Natural 
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experiment designs, often recommended as a way of understanding the impact of population-level 
policies on health outcomes, may be indicated to further explore the results shown in this present 
study.25 As with prospective trials, controlling for confounders and bias will be key when comparing 
exposed (high levels of NIHR research) and non- or low-exposed (lower levels of NIHR research) NHS 
Trusts.26 
The results of this study strongly support the notion that engagement by NHS Trusts and their staff 
in delivery of clinical trials, but not necessarily observational research, is positively associated with 
an improved organisational performance. This does not imply that the correlation is causal. 
Methodological constrictions mean that conducting prospective (randomised) trials to definitively 
identify factors contributing to these observations may be difficult. 
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Table 1, Spearman correlation analysis for individual variables 
 
 SHMI average CQC rating 
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Variable Rho p-value Rho p-value 
Overall  studies quotient -0.21 0.017* 0.23 0.008* 
Overall  participants quotient -0.28 0.001* 0.18 0.040* 
     
Observational   studies quotient -0.27 0.002* 0.26 0.003* 
Observational  participants quotient  -0.25 0.005* 0.12 0.19 
     
Interventional  studies  quotient -0.15 0.097 0.21 0.019* 
Interventional participants quotient -0.28 0.001* 0.27 0.002* 
*statistically significant correlation (p-value < 0.05) 
 
Table 2, backward multiple linear regression analysis: SHMI score as dependent 
Variable Standard coefficient 
Beta 
p-value  
Interventional  studies  quotient 0.36 0.030* 
Interventional participants quotient -0.44 0.002* 
Observational   studies quotient -0.21 0.13 
Observational  participants quotient  -0.13 0.25 
 
Most significant variable   
Interventional participants quotient -0.50 0.001* 
 *statistically significant correlation (p-value < 0.05) 
 
Table 3, backward multiple linear regression analysis: CQC rating as dependent 
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Variable Standard coefficient 
Beta 
p-value  
Interventional  studies  quotient -0.15 0.40 
Interventional participants quotient 0.28 0.056 
Observational   studies quotient 0.26 0.077 
Observational  participants quotient  -0.089 0.46 
 
Most significant variable   
Interventional participants quotient 0.26 0.003* 
*statistically significant correlation (p-value < 0.05) 
 
 
 
 
 
 
 
Figure 1,  Scatter plot number of interventional participant quotient and SHMI score 
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Figure 2,  Scatter plot number of interventional participant quotient and CQC rating 
 
 
 
Supplement 1, Summary tables of research performance by hospital Trust size 
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Table 4, Top and bottom five Hospital trusts by size and interventional participants quotient – Acute 
teaching hospital Trusts 
Trust name CQC rating Average SHMI 
score 
Interventional 
participant 
quotient* 
GUY'S AND ST THOMAS' NHS FT Good 0.77 4.15 
UNIVERSITY COLLEGE LONDON HOSPITALS NHS FT Good 0.76 2.91 
OXFORD UNIVERSITY HOSPITALS NHS TRUST Good 0.97 2.87 
THE NEWCASTLE UPON TYNE HOSPITALS NHS FT Outstanding 0.98 2.66 
UNIVERSITY HOSPITAL SOUTHAMPTON NHS FT Good 0.98 2.64 
Median values (n = 29) Good 0.98 1.72 
HULL AND EAST YORKSHIRE UNIVERSITY TEACHING 
HOSPITALS NHS FT Req. improv. 1.09 1.09 
YORK TEACHING HOSPITAL NHS FT Req. improv. 0.99 1.00 
SALFORD ROYAL NHS FT Outstanding 0.93 0.98 
ROYAL FREE LONDON NHS FT Good 0.88 0.92 
CHELSEA AND WESTMINSTER HOSPITAL NHS FT Req. improv. 0.84 0.87 
FT = Foundation Trust; Req. Improv. = requires improvement. *Participants recruited into interventional 
studies divided by total clinical staff number.  
 
Table 5, Top and bottom five Hospital trusts by size and interventional participants quotient – Large hospital 
Trusts 
Trust name CQC rating Average SHMI 
score 
Interventional 
participant 
quotient* 
HEART OF ENGLAND NHS FT Req. improv. 0.98 3.04 
CITY HOSPITALS SUNDERLAND NHS FT Good 1.03 1.63 
PLYMOUTH HOSPITALS NHS TRUST Req. improv. 0.99 1.52 
SOUTH TEES HOSPITALS NHS FT Good 1.05 1.37 
ROYAL CORNWALL HOSPITALS NHS TRUST Req. improv. 1.03 1.34 
Median values (n = 34) Req. improv. 1.03 0.70 
N. LINCOLNSHIRE AND GOOLE HOSPITALS NHS FT Inadequate 1.1 0.33 
EAST SUSSEX HEALTHCARE NHS TRUST Req. improv. 1.11 0.32 
DONCASTER AND BASSETLAW HOSPITALS NHS FT Req. improv. 1.05 0.27 
WIRRAL UNIVERSITY TEACHING HOSPITAL NHS FT Req. improv. 0.97 0.24 
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EPSOM AND ST HELIER UNIVERSITY HOSPITALS FT Req. improv. 0.97 0.17 
FT = Foundation Trust; Req. Improv. = requires improvement 
 
 
Table 6, Top and bottom five Hospital trusts by size and interventional participants quotient – Medium 
hospital Trusts 
Trust name CQC rating Average SHMI 
score 
Interventional 
participant 
quotient* 
ROYAL SURREY COUNTY HOSPITAL NHS FT Good 0.86 3.45 
ASHFORD AND ST PETER'S HOSPITALS NHS FT Good 0.94 1.67 
TAUNTON AND SOMERSET NHS FT Good 0.98 1.45 
ROYAL UNITED HOSPITAL BATH NHS TRUST Req. improv. 0.98 1.34 
GATESHEAD HEALTH NHS FT Good 0.99 1.33 
Median values (n = 42) Req. improv. 0.99 0.60 
LEWISHAM HEALTHCARE NHS TRUST Req. improv. 1.02 0.33 
STOCKPORT NHS FT Req. improv. 0.94 0.31 
WARRINGTON AND HALTON HOSPITALS NHS FT Req. improv. 1.12 0.30 
KINGSTON HOSPITAL NHS TRUST Req. improv. 0.89 0.27 
SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST Req. improv. 1.1 0.20 
FT = Foundation Trust; Req. Improv. = requires improvement 
 
Table 7, Top and bottom five Hospital trusts by size and interventional participants quotient – Small hospital 
Trusts 
Trust name CQC rating Average SHMI 
score 
Interventional 
participant 
quotient* 
YEOVIL DISTRICT HOSPITAL NHS FT Req. improv. 1.01 1.09 
HOMERTON UNIVERSITY HOSPITAL NHS FT Good 0.86 1.04 
DORSET COUNTY HOSPITAL NHS FT Req. improv. 1.13 0.98 
SOUTH TYNESIDE NHS FT Req. improv. 1.16 0.90 
HARROGATE AND DISTRICT NHS FT Good 0.96 0.85 
Median values (n = 24) Req. improv. 1.03 0.45 
MILTON KEYNES HOSPITAL NHS FT Good 1.02 0.29 
TAMESIDE HOSPITAL NHS FT Good 1.13 0.27 
WYE VALLEY NHS TRUST Req. improv. 1.17 0.27 
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ISLE OF WIGHT NHS TRUST Inadequate 1.02 0.25 
SOUTH WARWICKSHIRE GENERAL HOSPITALS NHS 
TRUST Req. improv. 1.06 0.18 
FT = Foundation Trust; Req. Improv. = requires improvement 
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Supplement 2 , Data analyses without acute teaching hospital Trusts. 
Table 8, Spearman correlation analysis for individual variables (without teaching hospitals) 
 SHMI average CQC rating 
Variable Rho p-value Rho p-value 
Overall  studies quotient -0.10 0.92 0.15 0.15 
Overall participants quotient -0.10 0.32 0.097 0.34 
     
Observational   studies quotient -0.12 0.25 0.15 0.14 
Observational  participants quotient  -0.057 0.57 -0.009 0.93 
     
Interventional  studies  quotient 0.092 0.36 0.12 0.25 
Interventional participants quotient -0.093 0.36 0.23 0.024* 
*statistically significant correlation (p-value < 0.05) 
 
Table 9, backward elimination multiple linear regression analysis: SHMI score as dependent 
(without teaching hospitals) 
Variable Standard coefficient Beta p-value  
Interventional  studies  quotient 0.39 0.018* 
Interventional participants quotient -0.34 0.008* 
Observational   studies quotient -0.20 0.16 
Observational  participants quotient  0.047 0.65 
 
Most significant variable   
Interventional participants quotient -0.31 0.014* 
 *statistically significant correlation (p-value < 0.05) 
 
Table 10, backward elimination multiple linear regression analysis: CQC rating as dependent 
(without teaching hospitals) 
Variable Standard coefficient Beta p-value  
Interventional  studies  quotient -0.20 0.23 
Interventional participants quotient 0.27 0.039* 
Observational   studies quotient 0.13 0.36 
Observational  participants quotient  -0.012 0.91 
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Most significant variable   
Interventional participants quotient 0.19 0.062 
*statistically significant correlation (p-value < 0.05) 
 
 
